Skip to content

Dideco Flexible Reservoir -- Product Designation 5063

by Sorin Biomedical, Inc.

510(k) K945065

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK945065 Date19 May 1995ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DTN
Device Class
Class II
Regulation
21 CFR Part 870.4400
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Dideco Flexible Reservoir -- Product Designation 5063 is a Reservoir, Blood, Cardiopulmonary Bypass, designed for use in cardiopulmonary bypass procedures. It serves as a collection and storage container for blood and other fluids during open-heart surgeries, ensuring safe and efficient circulation management during cardiac interventions.

This device is intended for single-use in controlled clinical settings, such as operating rooms, and is classified as a Class II medical device under FDA regulation 870.4400. It has received FDA 510K clearance as substantially equivalent to predicate devices, with no explicit sterility or MRI safety specifications noted. The flexible construction accommodates varying volumes of fluid, and its design adheres to cardiovascular surgical standards for cardiopulmonary support.

Other devices from Sorin Biomedical, Inc.

See all devices from Sorin Biomedical, Inc. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary use of the Dideco Flexible Reservoir -- Product Designation 5063 in surgical settings?

    The Dideco Flexible Reservoir -- Product Designation 5063 is specifically designed for cardiopulmonary bypass procedures during open-heart surgeries. It serves as a collection and storage container for blood and other fluids, ensuring safe and efficient circulation management throughout the cardiac intervention.

  • Is the Dideco Flexible Reservoir intended for single-use or repeated use in clinical environments?

    This device is explicitly intended for single-use in controlled clinical settings, such as operating rooms. Its flexible construction and design align with standards for cardiopulmonary support, making it unsuitable for reuse.

  • What regulatory pathway was followed for FDA clearance of this device, and what classification does it hold?

    The Dideco Flexible Reservoir received FDA 510K clearance under the Traditional 510(k) pathway, determined to be substantially equivalent to predicate devices. It is classified as a Class II medical device under FDA regulation 21 CFR 870.4400, reflecting its role in cardiopulmonary bypass procedures.

  • Are there any specific volume or size variations available for this reservoir, and how is it typically supplied?

    While the exact volume specifications are not detailed in the provided data, the device’s flexible construction suggests it is engineered to accommodate varying volumes of blood and fluids during cardiopulmonary bypass. It is supplied as a sterile, single-use item, intended for immediate use in surgical settings without reprocessing.

  • What type of advisory committee reviewed this device submission, and what was the focus of their evaluation?

    The submission for the Dideco Flexible Reservoir was reviewed by the FDA Cardiovascular (CV) Advisory Committee, which evaluates devices related to cardiovascular surgical procedures. The committee’s focus aligns with the device’s intended use in cardiovascular interventions, particularly those involving cardiopulmonary bypass.